Table of Contents:
- Implementing cellular therapies in mantle cell lymphoma
- BHS guidelines on supportive care in lymphoma: Part 1
- The role of venetoclax in the current treatment paradigm for patients with acute myeloid leukaemia
- Myeloid lineage switching as escape mechanism to chimeric antigen receptor T-cell therapy in precursor B-ALL with ZNF384-TCF3 fusion: A case report
- Highlights from EAHAD 2022
- Journal scan
